HIV-1 (Human Immunodeficiency Virus Type 1) Extended Drug Resistance, EDTA Plasma

HIV Drug Resistance Test Overview

The HIV drug resistance test is a crucial diagnostic tool that identifies mutations in the HIV virus that make it resistant to antiretroviral therapy (ART). This test helps healthcare providers select the most effective treatment regimen for patients by determining whether the HIV strain is susceptible or resistant to various antiretroviral drugs. The test involves genotypic testing, which sequences the viral genome's protease, integrase, and reverse transcriptase genes to identify mutations associated with drug resistance. Next Generation Sequencing and comparison with databases like the Stanford HIVDB are commonly used for this purpose.

The HIV drug resistance test is essential for managing HIV infection effectively. By identifying drug-resistant strains of HIV, healthcare providers can tailor treatment plans to the individual patient's needs, ensuring the best possible outcomes. This test is particularly important in cases of treatment failure, where drug resistance may be the underlying cause.

HIV-1 Drug Resistance testing is used to evaluate whether a patient with human immunodeficiency virus (HIV) has a mutated form of the virus that does not respond to antiretroviral therapy (ART) as expected. ART involves taking a combination of HIV medicines that can help control the replication of the virus.